Echidnas' extremely rare reverse path through evolution
The echidna is among the first modern mammals to take the "extremely rare" path out of water for life on the land, surprising Australian researchers.
The discovery came during analysis of a fossilised bone of an ancient echidna found 30 years ago in Victoria.
When studying the 108-million-year-old upper arm bone, Professor Suzanne Hand noticed it had attributes similar to a semiaquatic mammal.
More than 30 modern mammal species have transitioned from land to water, such as whales, otters and dolphins.
But the professor said it is "extremely rare" to see the opposite occur.
"We've had mammals going from water to land and land to water," Prof Hand told AAP on Wednesday.
"But in terms of modern mammals (those living after the dinosaur age), we've mostly seen mammals go from land to water."
The modern-day prickly creature also has muscles that help it conserve oxygen when burrowing, similar to the tissues platypuses use to dive.
Scientists found similar muscles in the fossil, helping them conclude that echidnas evolved from a water species.
Echidnas and platypuses, both belonging to the family of egg-laying mammals, are considered distant relatives as they have backwards feet and similar beak receptors to detect prey.
"The microstructure of the fossil's humerus (arm bone) is more like the internal bone structure seen in platypuses," Prof Hand said.
"The (muscles) are high in the platypus, but are higher than expected in echidnas, even as burrowers."
But a burning question arises: when did the echidna move to land?
Scientists predict it happened between 23 million and 66 million years ago.
They hope to find fossil proof in northwest NSW that can confirm their suspicions.
"We're increasing our efforts to help investigate the opalised fossils of Lightning Ridge which are about the same age as the Victorian fossil deposits," Prof Archer said.
"We're hoping we'll discover other ancestral monotremes (egg-laying mammals) that will help unravel the early history of this most fascinating group of mammals."
Researchers will also examine the Kryoryctes cadburyi fossilised bone through imaging and scans to understand it better.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Advertiser
6 hours ago
- The Advertiser
Regional students to capture the sun in science program
Students at two schools near major renewable energy projects will be challenged to create solar-powered toy cars and design sustainable houses in bid to foster science education in regional areas. Major energy retailer Alinta and the Australian Academy of Technical Science and Engineering launched their partnership on Monday, revealing an extension to the STELR education program for schools in NSW and South Australia. The announcement comes days after Women 4 STEM called for greater funding to encourage students to study science, technology engineering and maths in regional areas, amid fears artificial intelligence technology could disadvantage girls in particular. Alinta will fund science kits for students at Melville High School near its Oven Mountain pumped hydro project in NSW, and at Gawler and District College in South Australia, near its Reeves Plains battery storage hub. The schools were chosen for their proximity to renewable energy projects to foster curiosity about jobs in the growing future industry, Alinta chief executive Jeff Dimery said. "It's about creating real connections between students, their communities and the future of energy," Mr Dimery said. "By supporting schools near our future renewable energy sites, we're helping young people see themselves in the energy transition and giving them the tools to be part of it." The energy firm will also provide in-person training for teachers, in addition to online resources and renewable energy kits that include mini solar panels and houses. The STELR program, which began in 2008, has reached more than one million Australian students. Teaching children science in a practical way would be vital to support the next generation of energy workers, academy chief executive Kylie Walker said. "To effectively transition Australia's energy towards low-carbon and zero-carbon solutions, it's urgent that we educate and inspire school students and empower them to make the most of the careers of the future," she said. "Supporting hands-on science, technology and engineering education in schools benefits students, teachers, society and the economy by building the skills, capability and motivations of the highly capable professionals who will deliver the energy projects of the future." A federal Education Department study found 15-year-olds in remote areas of Australia were 1.5 years behind their urban peers in science studies on average, and performed significantly below the international average in mathematics. Challenges identified by the research included limited access to resources and difficulty finding and retaining qualified science teachers. Students at two schools near major renewable energy projects will be challenged to create solar-powered toy cars and design sustainable houses in bid to foster science education in regional areas. Major energy retailer Alinta and the Australian Academy of Technical Science and Engineering launched their partnership on Monday, revealing an extension to the STELR education program for schools in NSW and South Australia. The announcement comes days after Women 4 STEM called for greater funding to encourage students to study science, technology engineering and maths in regional areas, amid fears artificial intelligence technology could disadvantage girls in particular. Alinta will fund science kits for students at Melville High School near its Oven Mountain pumped hydro project in NSW, and at Gawler and District College in South Australia, near its Reeves Plains battery storage hub. The schools were chosen for their proximity to renewable energy projects to foster curiosity about jobs in the growing future industry, Alinta chief executive Jeff Dimery said. "It's about creating real connections between students, their communities and the future of energy," Mr Dimery said. "By supporting schools near our future renewable energy sites, we're helping young people see themselves in the energy transition and giving them the tools to be part of it." The energy firm will also provide in-person training for teachers, in addition to online resources and renewable energy kits that include mini solar panels and houses. The STELR program, which began in 2008, has reached more than one million Australian students. Teaching children science in a practical way would be vital to support the next generation of energy workers, academy chief executive Kylie Walker said. "To effectively transition Australia's energy towards low-carbon and zero-carbon solutions, it's urgent that we educate and inspire school students and empower them to make the most of the careers of the future," she said. "Supporting hands-on science, technology and engineering education in schools benefits students, teachers, society and the economy by building the skills, capability and motivations of the highly capable professionals who will deliver the energy projects of the future." A federal Education Department study found 15-year-olds in remote areas of Australia were 1.5 years behind their urban peers in science studies on average, and performed significantly below the international average in mathematics. Challenges identified by the research included limited access to resources and difficulty finding and retaining qualified science teachers. Students at two schools near major renewable energy projects will be challenged to create solar-powered toy cars and design sustainable houses in bid to foster science education in regional areas. Major energy retailer Alinta and the Australian Academy of Technical Science and Engineering launched their partnership on Monday, revealing an extension to the STELR education program for schools in NSW and South Australia. The announcement comes days after Women 4 STEM called for greater funding to encourage students to study science, technology engineering and maths in regional areas, amid fears artificial intelligence technology could disadvantage girls in particular. Alinta will fund science kits for students at Melville High School near its Oven Mountain pumped hydro project in NSW, and at Gawler and District College in South Australia, near its Reeves Plains battery storage hub. The schools were chosen for their proximity to renewable energy projects to foster curiosity about jobs in the growing future industry, Alinta chief executive Jeff Dimery said. "It's about creating real connections between students, their communities and the future of energy," Mr Dimery said. "By supporting schools near our future renewable energy sites, we're helping young people see themselves in the energy transition and giving them the tools to be part of it." The energy firm will also provide in-person training for teachers, in addition to online resources and renewable energy kits that include mini solar panels and houses. The STELR program, which began in 2008, has reached more than one million Australian students. Teaching children science in a practical way would be vital to support the next generation of energy workers, academy chief executive Kylie Walker said. "To effectively transition Australia's energy towards low-carbon and zero-carbon solutions, it's urgent that we educate and inspire school students and empower them to make the most of the careers of the future," she said. "Supporting hands-on science, technology and engineering education in schools benefits students, teachers, society and the economy by building the skills, capability and motivations of the highly capable professionals who will deliver the energy projects of the future." A federal Education Department study found 15-year-olds in remote areas of Australia were 1.5 years behind their urban peers in science studies on average, and performed significantly below the international average in mathematics. Challenges identified by the research included limited access to resources and difficulty finding and retaining qualified science teachers. Students at two schools near major renewable energy projects will be challenged to create solar-powered toy cars and design sustainable houses in bid to foster science education in regional areas. Major energy retailer Alinta and the Australian Academy of Technical Science and Engineering launched their partnership on Monday, revealing an extension to the STELR education program for schools in NSW and South Australia. The announcement comes days after Women 4 STEM called for greater funding to encourage students to study science, technology engineering and maths in regional areas, amid fears artificial intelligence technology could disadvantage girls in particular. Alinta will fund science kits for students at Melville High School near its Oven Mountain pumped hydro project in NSW, and at Gawler and District College in South Australia, near its Reeves Plains battery storage hub. The schools were chosen for their proximity to renewable energy projects to foster curiosity about jobs in the growing future industry, Alinta chief executive Jeff Dimery said. "It's about creating real connections between students, their communities and the future of energy," Mr Dimery said. "By supporting schools near our future renewable energy sites, we're helping young people see themselves in the energy transition and giving them the tools to be part of it." The energy firm will also provide in-person training for teachers, in addition to online resources and renewable energy kits that include mini solar panels and houses. The STELR program, which began in 2008, has reached more than one million Australian students. Teaching children science in a practical way would be vital to support the next generation of energy workers, academy chief executive Kylie Walker said. "To effectively transition Australia's energy towards low-carbon and zero-carbon solutions, it's urgent that we educate and inspire school students and empower them to make the most of the careers of the future," she said. "Supporting hands-on science, technology and engineering education in schools benefits students, teachers, society and the economy by building the skills, capability and motivations of the highly capable professionals who will deliver the energy projects of the future." A federal Education Department study found 15-year-olds in remote areas of Australia were 1.5 years behind their urban peers in science studies on average, and performed significantly below the international average in mathematics. Challenges identified by the research included limited access to resources and difficulty finding and retaining qualified science teachers.
Perth Now
9 hours ago
- Perth Now
Regional students to capture the sun in science program
Students at two schools near major renewable energy projects will be challenged to create solar-powered toy cars and design sustainable houses in bid to foster science education in regional areas. Major energy retailer Alinta and the Australian Academy of Technical Science and Engineering launched their partnership on Monday, revealing an extension to the STELR education program for schools in NSW and South Australia. The announcement comes days after Women 4 STEM called for greater funding to encourage students to study science, technology engineering and maths in regional areas, amid fears artificial intelligence technology could disadvantage girls in particular. Alinta will fund science kits for students at Melville High School near its Oven Mountain pumped hydro project in NSW, and at Gawler and District College in South Australia, near its Reeves Plains battery storage hub. The schools were chosen for their proximity to renewable energy projects to foster curiosity about jobs in the growing future industry, Alinta chief executive Jeff Dimery said. "It's about creating real connections between students, their communities and the future of energy," Mr Dimery said. "By supporting schools near our future renewable energy sites, we're helping young people see themselves in the energy transition and giving them the tools to be part of it." The energy firm will also provide in-person training for teachers, in addition to online resources and renewable energy kits that include mini solar panels and houses. The STELR program, which began in 2008, has reached more than one million Australian students. Teaching children science in a practical way would be vital to support the next generation of energy workers, academy chief executive Kylie Walker said. "To effectively transition Australia's energy towards low-carbon and zero-carbon solutions, it's urgent that we educate and inspire school students and empower them to make the most of the careers of the future," she said. "Supporting hands-on science, technology and engineering education in schools benefits students, teachers, society and the economy by building the skills, capability and motivations of the highly capable professionals who will deliver the energy projects of the future." A federal Education Department study found 15-year-olds in remote areas of Australia were 1.5 years behind their urban peers in science studies on average, and performed significantly below the international average in mathematics. Challenges identified by the research included limited access to resources and difficulty finding and retaining qualified science teachers.
The Advertiser
a day ago
- The Advertiser
'Game changer' diabetes pill a step closer after trials
Game-changing diabetes pills could hit Australian shelves within years, offering an alternative to popular injectable treatments like Ozempic that have been plagued with supply issues. That's the prediction from Australian diabetes experts, as the first phase three clinical trial data was released for a new type of medicine that lowers blood sugar. Once-a-day pill Orforglipron was shown to imitate a naturally occurring hormone that helps regulate blood sugar and appetite, according to the study published in the prestigious New England Journal of Medicine. "It's really, really exciting," Australian Diabetes Society chief executive Associate Professor Sof Andrikopoulos told AAP. "The reduction in blood glucose and weight with Orforglipron is similar, if not a little bit better, than the similar clinical trials that were done for Ozempic and Mounjaro." The results of the trials, involving 500 adults with type 2 diabetes, were unveiled at the American Diabetes Association annual meeting in Chicago over the weekend. Reported side effects were similar to existing medications like gastrointestinal issues, while the drug company did not flag any unexpected safety concerns. The trial focused on diabetes treatment and not specifically weight loss. Other oral diabetes medications already exist but this medication is significant as it's the first synthetic treatment to reach phase three trials, Prof Andrikopoulos said. He expected approval from the Therapeutic Goods Administration would be "reasonable straightforward" once it receives an application by drug developer Eli Lilly, which also makes Mounjaro. The synthetic chemical is easier to make than other drugs involving modified peptides and doesn't need to be refrigerated, hoping it would be cheaper and easier to transport to remote areas than injectable treatments. "These are potentially disease modifying therapies, and in that respect it's a game-changer," Prof Andrikopoulos said. "In terms of managing types of diabetes and obesity, I think we are at the cusp of being able to make a significant impact on reducing obesity in Australia and around the world." Sydney-based Endocrinologist Associate Professor Ted Wu treats many patients with diabetes and said physicians had been "crying out" for oral alternatives to incretin injections. While optimistic about the findings, he cautioned it was not a "head to head" trial measuring the effectiveness of Orforglipron against injections but said it appears the results were very similar. "As it stands, this looks like it offers all the advantages of the current incretin injections, but with all the advantages of an oral once-a-day medication and hopefully with far fewer supply issues," he said. Prof Wu said looking at past performance, the TGA would probably take between 12 and 24 months to approve the new drug. Game-changing diabetes pills could hit Australian shelves within years, offering an alternative to popular injectable treatments like Ozempic that have been plagued with supply issues. That's the prediction from Australian diabetes experts, as the first phase three clinical trial data was released for a new type of medicine that lowers blood sugar. Once-a-day pill Orforglipron was shown to imitate a naturally occurring hormone that helps regulate blood sugar and appetite, according to the study published in the prestigious New England Journal of Medicine. "It's really, really exciting," Australian Diabetes Society chief executive Associate Professor Sof Andrikopoulos told AAP. "The reduction in blood glucose and weight with Orforglipron is similar, if not a little bit better, than the similar clinical trials that were done for Ozempic and Mounjaro." The results of the trials, involving 500 adults with type 2 diabetes, were unveiled at the American Diabetes Association annual meeting in Chicago over the weekend. Reported side effects were similar to existing medications like gastrointestinal issues, while the drug company did not flag any unexpected safety concerns. The trial focused on diabetes treatment and not specifically weight loss. Other oral diabetes medications already exist but this medication is significant as it's the first synthetic treatment to reach phase three trials, Prof Andrikopoulos said. He expected approval from the Therapeutic Goods Administration would be "reasonable straightforward" once it receives an application by drug developer Eli Lilly, which also makes Mounjaro. The synthetic chemical is easier to make than other drugs involving modified peptides and doesn't need to be refrigerated, hoping it would be cheaper and easier to transport to remote areas than injectable treatments. "These are potentially disease modifying therapies, and in that respect it's a game-changer," Prof Andrikopoulos said. "In terms of managing types of diabetes and obesity, I think we are at the cusp of being able to make a significant impact on reducing obesity in Australia and around the world." Sydney-based Endocrinologist Associate Professor Ted Wu treats many patients with diabetes and said physicians had been "crying out" for oral alternatives to incretin injections. While optimistic about the findings, he cautioned it was not a "head to head" trial measuring the effectiveness of Orforglipron against injections but said it appears the results were very similar. "As it stands, this looks like it offers all the advantages of the current incretin injections, but with all the advantages of an oral once-a-day medication and hopefully with far fewer supply issues," he said. Prof Wu said looking at past performance, the TGA would probably take between 12 and 24 months to approve the new drug. Game-changing diabetes pills could hit Australian shelves within years, offering an alternative to popular injectable treatments like Ozempic that have been plagued with supply issues. That's the prediction from Australian diabetes experts, as the first phase three clinical trial data was released for a new type of medicine that lowers blood sugar. Once-a-day pill Orforglipron was shown to imitate a naturally occurring hormone that helps regulate blood sugar and appetite, according to the study published in the prestigious New England Journal of Medicine. "It's really, really exciting," Australian Diabetes Society chief executive Associate Professor Sof Andrikopoulos told AAP. "The reduction in blood glucose and weight with Orforglipron is similar, if not a little bit better, than the similar clinical trials that were done for Ozempic and Mounjaro." The results of the trials, involving 500 adults with type 2 diabetes, were unveiled at the American Diabetes Association annual meeting in Chicago over the weekend. Reported side effects were similar to existing medications like gastrointestinal issues, while the drug company did not flag any unexpected safety concerns. The trial focused on diabetes treatment and not specifically weight loss. Other oral diabetes medications already exist but this medication is significant as it's the first synthetic treatment to reach phase three trials, Prof Andrikopoulos said. He expected approval from the Therapeutic Goods Administration would be "reasonable straightforward" once it receives an application by drug developer Eli Lilly, which also makes Mounjaro. The synthetic chemical is easier to make than other drugs involving modified peptides and doesn't need to be refrigerated, hoping it would be cheaper and easier to transport to remote areas than injectable treatments. "These are potentially disease modifying therapies, and in that respect it's a game-changer," Prof Andrikopoulos said. "In terms of managing types of diabetes and obesity, I think we are at the cusp of being able to make a significant impact on reducing obesity in Australia and around the world." Sydney-based Endocrinologist Associate Professor Ted Wu treats many patients with diabetes and said physicians had been "crying out" for oral alternatives to incretin injections. While optimistic about the findings, he cautioned it was not a "head to head" trial measuring the effectiveness of Orforglipron against injections but said it appears the results were very similar. "As it stands, this looks like it offers all the advantages of the current incretin injections, but with all the advantages of an oral once-a-day medication and hopefully with far fewer supply issues," he said. Prof Wu said looking at past performance, the TGA would probably take between 12 and 24 months to approve the new drug. Game-changing diabetes pills could hit Australian shelves within years, offering an alternative to popular injectable treatments like Ozempic that have been plagued with supply issues. That's the prediction from Australian diabetes experts, as the first phase three clinical trial data was released for a new type of medicine that lowers blood sugar. Once-a-day pill Orforglipron was shown to imitate a naturally occurring hormone that helps regulate blood sugar and appetite, according to the study published in the prestigious New England Journal of Medicine. "It's really, really exciting," Australian Diabetes Society chief executive Associate Professor Sof Andrikopoulos told AAP. "The reduction in blood glucose and weight with Orforglipron is similar, if not a little bit better, than the similar clinical trials that were done for Ozempic and Mounjaro." The results of the trials, involving 500 adults with type 2 diabetes, were unveiled at the American Diabetes Association annual meeting in Chicago over the weekend. Reported side effects were similar to existing medications like gastrointestinal issues, while the drug company did not flag any unexpected safety concerns. The trial focused on diabetes treatment and not specifically weight loss. Other oral diabetes medications already exist but this medication is significant as it's the first synthetic treatment to reach phase three trials, Prof Andrikopoulos said. He expected approval from the Therapeutic Goods Administration would be "reasonable straightforward" once it receives an application by drug developer Eli Lilly, which also makes Mounjaro. The synthetic chemical is easier to make than other drugs involving modified peptides and doesn't need to be refrigerated, hoping it would be cheaper and easier to transport to remote areas than injectable treatments. "These are potentially disease modifying therapies, and in that respect it's a game-changer," Prof Andrikopoulos said. "In terms of managing types of diabetes and obesity, I think we are at the cusp of being able to make a significant impact on reducing obesity in Australia and around the world." Sydney-based Endocrinologist Associate Professor Ted Wu treats many patients with diabetes and said physicians had been "crying out" for oral alternatives to incretin injections. While optimistic about the findings, he cautioned it was not a "head to head" trial measuring the effectiveness of Orforglipron against injections but said it appears the results were very similar. "As it stands, this looks like it offers all the advantages of the current incretin injections, but with all the advantages of an oral once-a-day medication and hopefully with far fewer supply issues," he said. Prof Wu said looking at past performance, the TGA would probably take between 12 and 24 months to approve the new drug.
